Patent US4131682A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4131682A Expired / Lapsed US ⏱️ 0.0 years remaining

Heteroaryl ketone derivatives

Assignee: Lilly Industries Ltd
•
Filing: 1977-10-11
•
Granted: 1978-12-26
•
Expires: 1997-10-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel heteroaryl ketone derivatives, specifically a class of phenyl heteroaryl methanone derivatives, having anti-allergy activity, pharmaceutical formulations containing diphenylmethane derivatives and methods of treatment utilizing such derivatives.

Inventors

  • 👤 Delme Evans
  • 👤 John C. Saunders
  • 👤 William R. N. Williamson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 01:17
CPC Classifications
C; C07; C07D; C07D207/00; C07D207/02; C07D207/30; C07D207/32; C07D207/33; C07D207/333; C07D333/00; C07D333/02; C07D333/04; C07D333/06; C07D333/22; C07D333/26; C07D333/28

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 57 words
A heteroaryl ketone derivative of formula ##STR5## wherein R 1 is C 1-4 alkyl and Het is a heteroaryl group selected from thienyl and thienyl substituted by from one to three groups selected from halogen and C 1-4 alkyl, or a pharmaceutically acceptable salt thereof, provided that when Het is 2-thienyl, R 1 is C 2-4 alkyl.
Claim 2
Dependent Claim 57 words
A heteroaryl ketone derivative of formula ##STR5## wherein R 1 is C 1-4 alkyl and Het is a heteroaryl group selected from thienyl and thienyl substituted by from one to three groups selected from halogen and C 1-4 alkyl, or a pharmaceutically acceptable salt thereof, provided that when Het is 2-thienyl, R 1 is C 2-4 alkyl.
Claim 3
Dependent Claim 12 words
The compound of claim 1 wherein R 1 is C 2-4 alkyl.
Claim 4
Dependent Claim 10 words
The compound of claim 2 wherein R 1 is ethyl.
Claim 5
Dependent Claim 14 words
The compound of claim 2 wherein Het is selected from thienyl, halothienyl, and methylthienyl.
Claim 6
Dependent Claim 9 words
The compound of claim 3 wherein Het is 2-thienyl.
Claim 7
Dependent Claim 66 words
A pharmaceutical formulation consisting essentially of a therapeutically effectaive amount of an active ingredient being a compound of formula (I) ##STR6## where R 1 is C 1-4 alkyl and Het is a heteroaryl group selected from thienyl and thienyl substituted by from one to three groups selected from halogen and C 1-4 alkyl, or a pharmaceutically acceptable salt thereof; associated with a pharmaceutically acceptable carrier therefor.
Claim 8
Dependent Claim 66 words
A pharmaceutical formulation consisting essentially of a therapeutically effectaive amount of an active ingredient being a compound of formula (I) ##STR6## where R 1 is C 1-4 alkyl and Het is a heteroaryl group selected from thienyl and thienyl substituted by from one to three groups selected from halogen and C 1-4 alkyl, or a pharmaceutically acceptable salt thereof; associated with a pharmaceutically acceptable carrier therefor.
Claim 9
Independent Claim 67 words
A method of treating immediate hypersensitivity diseases in animals, including humans, which comprises administering to an afflicted animal a chemotherapeutically effective amount of a compound of formula (I) ##STR7## wherein R 1 is C 1-4 alkyl and Het is a heteroaryl group selected from thienyl and thienyl substituted by from one to three groups selected from halogen and C 1-4 alkyl, or a pharmaceutically acceptable salt thereof.
Claim 10
Independent Claim 67 words
A method of treating immediate hypersensitivity diseases in animals, including humans, which comprises administering to an afflicted animal a chemotherapeutically effective amount of a compound of formula (I) ##STR7## wherein R 1 is C 1-4 alkyl and Het is a heteroaryl group selected from thienyl and thienyl substituted by from one to three groups selected from halogen and C 1-4 alkyl, or a pharmaceutically acceptable salt thereof.

References Cited (Backward Citations)

US4000160A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-12-25 1982-06-26 1982-12-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-12-25 1986-06-26 1986-12-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-12-25 1990-06-26 1990-12-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag